Responses
Therapeutics
Systematic review and meta-analysis
High-dose statin before percutaneous coronary intervention lowers risk of periprocedural myocardial infarction and 30-day major cardiac adverse events
Compose a Response to This Article
Other responses
No responses have been published for this article.